DexCom (FRA:DC4) Short Interest


FRA:DC4 DexCom Inc FRA:DC4
90 GF Score
Price €60.40
GF Value €91.13
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Short Interest?

Short Interest can be expressed as a percentage by dividing the number of shares sold short by the total number of outstanding shares.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

FRA:DC4 vs GEHC, STE, ZBH: Short Interest Comparison

For the Medical Devices subindustry, DexCom's Short Interest, along with its competitors' market caps and Short Interest data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

DexCom Short Interest vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Short Interest distribution charts can be found below:

* The bar in red indicates where DexCom's Short Interest falls into.


FRA:DC4
90GF Score
DexCom Inc FRA:DC4
Short Interest is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is DexCom (FRA:DC4) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of €60.40 is trading 33.7% below its estimated GF Value™ of €91.13. GuruFocus considers DexCom to be Significantly Undervalued.

Key valuation signals for FRA:DC4:

  • Short Interest:
  • GF Value™: €91.13 vs. price of €60.40 (33.7% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the FRA:DC4 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score

Get the complete analysis for FRA:DC4

Short Interest is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€60.40
Price
€91.13
GF Value